IM-3

$33.50
RV97

IM-3 is a practitioner-only listed medicine formulated with Cordyceps sinensis and Ganoderma lucidum. It is intended for qualified healthcare practitioners seeking traditional Chinese medicine support for Qi, shen regulation, heart nourishment and cough relief.

60 x 500 mg capsules | AUST L 165996

Each capsule contains:

Cordyceps sinensis hyphae dry extract 250 mg
Equivalent to dry Cordyceps sinensis hyphae 1.25 g
Extract ratio 5:1

Ganoderma lucidum hyphae dry extract 250 mg
Equivalent to dry Ganoderma lucidum hyphae 1.25 g
Extract ratio 5:1

Traditionally used in Chinese medicine to:

  • tonify, nourish, strengthen and replenish Qi
  • calm, stabilise, settle and regulate shen
  • nourish the heart
  • relieve cough

Directions

Take 1 capsule twice daily, or as directed by a qualified healthcare practitioner.

Maximum daily dose: 5 capsules daily.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment and must not exceed the ARTG-listed maximum daily dose.

Label statements

If symptoms persist, talk to your health professional.

Adults only.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level, pathway-level and traditional-use research relating to Cordyceps sinensis, Ganoderma lucidum, Qi support, shen regulation, cough support and medicinal mushroom polysaccharides. It does not represent additional ARTG indications for IM-3.

IM-3 is relevant to practitioners interested in Cordyceps and Ganoderma research, traditional Qi support, shen regulation, heart nourishment, cough support, medicinal mushroom polysaccharides, beta-glucans, antioxidant pathways and immune system pathway research.

Cordyceps sinensis is traditionally used in Chinese medicine in Qi-supporting and respiratory-support contexts. Recent review literature has discussed Cordyceps polysaccharides in relation to immune pathway research, macrophage activity, lymphocyte-related research, oxidative stress and broader biological activity. This information is provided as ingredient-level education only and should not be interpreted as a claim that IM-3 treats immune deficiency, infection, cancer, chronic fatigue syndrome or renal disease.

Ganoderma lucidum, also known as Lingzhi or Reishi, is traditionally used in Chinese medicine and has been widely discussed in professional literature in relation to polysaccharides, triterpenes, antioxidant pathways, inflammatory pathways, immune pathway research and traditional shen-calming use. Recent review literature has examined Ganoderma lucidum polysaccharides, including preparation, structure, physicochemical properties and applications.

Recent review literature has also discussed Ganoderma lucidum bioactive compounds in relation to immunomodulatory, anti-inflammatory and antioxidant mechanisms, particularly in gut-liver-brain axis research contexts. This supports practitioner education around Ganoderma’s broader pathway-level research profile, without creating additional therapeutic indications for IM-3.

The combination of Cordyceps sinensis and Ganoderma lucidum supports practitioner education around traditional Qi support, shen regulation, cough support, medicinal mushroom polysaccharides and immune pathway research.

This information is provided for practitioner education only and does not represent additional ARTG indications for IM-3.

References available to registered practitioners on request.